Remove 2010 Remove Cannabis Remove Research and Development Remove Treatment
article thumbnail

Awakn Life Sciences Appoints Addiction Expert Prof. David Nutt as Chief Research Officer

Cannabis Law Report

Nutt Will Drive Progression of a Pipeline of New Psychedelic Medicines, Helping to Define a Clear Development Pathway to Treat Addiction Through Psychedelic Medicines. David Nutt, has joined its executive team as Chief Research Officer. Toronto, Ontario–(Newsfile Corp. June 24, 2021) – Awakn Life Sciences Corp.

article thumbnail

Using Cannabis for ALS: Benefits, Research and Best Strains

Greencamp

In this comprehensive guide, we are exploring the research on using cannabis for treating Amyotrophic lateral sclerosis (ALS)—a rare neuron disease that targets the motor neurons in the body. Exploring the available research on ALS and cannabinoids. Marijuana and Epilepsy: Here’s How Cannabis Stops Seizures (12 Studies).

Strains 94
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

1 Kilogram of Cannabis Was the (Ultimate) Price of This Singaporean Man’s Life

Veriheal

On April 26, Singaporean authorities at Changi prison executed Singaporean Tamil national Tangaraju Suppiah, 46, who was purportedly involved in the trafficking of 1 kilogram of cannabis—a crime that his family believes he is innocent of committing. grams of cannabis in 2017.

article thumbnail

Leading Investment Fund in the Psychedelics and Mental Health Space Issues Statement on atai Life Sciences IPO Listing

Cannabis Law Report

PUBLISHER: CANNABIS LAW REPORT. Palo Santo has a notable stake in atai, a global biopharmaceutical company developing psychedelic and non-psychedelic compounds for various mental health indications. In 2010, the direct and indirect cost of mental health conditions worldwide was estimated to be $2.5 trillion by 2030.

article thumbnail

The Effort to Decriminalize Psilocybin in California is Underway

Canna Law Blog

Psilocybin has been in the news with increasing frequency as research into psychedelic therapy has proliferated, and a number of local jurisdictions, including the cities of Oakland, Denver , and Santa Cruz have decriminalized psilocybin to varying degrees. Magic Mushrooms are much safer than caffeine, nicotine, and alcohol.

article thumbnail

Investment Fund in the Psychedelics and Mental Health Space Issues Statement on atai Life Sciences IPO Listing

Cannabis Law Report

June 18, 2021 (Chicago) — Palo Santo , the leading psychedelic investment fund helping to increase the supply of clinically effective and accessible mental health and addiction treatment solutions, issued the following statement regarding atai Life Sciences ’ (“atai” or “Company”) ( NASDAQ: ATAI ) initial public offering.

article thumbnail

Cannabis – The study that blew my mind

Cannabis Law Report

I was a young cannabis research student on my first trip overseas to an international research conference. Events like these afford us a glimpse into the future of research and medicine in this field. At current, transplant treatments are hindered by our understanding of the immune response of those receiving treatments.